Co-Diagnostics, Inc. (CODX)
2.275
-0.22
(-9.00%)
USD |
NASDAQ |
Mar 17, 16:00
2.26
-0.02
(-0.66%)
After-Hours: 18:06
Co-Diagnostics Market Cap : 4.766M for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 1.973B |
| Plus Therapeutics, Inc. | 45.22M |
| Atossa Therapeutics, Inc. | 47.28M |
| Abeona Therapeutics, Inc. | 258.49M |
| Cell Source, Inc. | 39.63M |
Market Cap Related Metrics
| PS Ratio | 39.77 |
| PEG Ratio | -0.0001 |
| Price to Book Value | 0.1197 |
| Price | 2.275 |
| Earnings Yield | -963.2% |
| PEGY Ratio | -0.0001 |